Development
SpringWorks Therapeutics, Inc.
SWTX
NASDAQ
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 479.20M | 422.42M | 476.71M | 528.14M | 592.21M |
| Total Receivables | 5.93M | -- | -- | -- | -- |
| Inventory | 3.10M | -- | -- | -- | -- |
| Prepaid Expenses | 12.68M | 9.96M | 7.19M | 9.52M | 7.55M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 500.91M | 432.38M | 483.90M | 537.66M | 599.76M |
|
|
|||||
| Total Current Assets | 500.91M | 432.38M | 483.90M | 537.66M | 599.76M |
| Net Property, Plant & Equipment | 24.09M | 27.39M | 25.00M | 22.33M | 18.27M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 11.20M | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 4.25M | 4.09M | 3.61M | 3.50M | 3.23M |
| Total Assets | 725.79M | 467.65M | 517.33M | 569.20M | 630.24M |
|
|
|||||
| Total Accounts Payable | 7.40M | 5.55M | 3.45M | 6.99M | 8.01M |
| Total Accrued Expenses | 65.57M | 40.33M | 35.28M | 28.69M | 39.24M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.06M | 1.16M | 811.00K | 386.00K | 483.00K |
| Total Finance Division Other Current Liabilities | 4.14M | 3.24M | 2.36M | 1.69M | 3.31M |
| Total Other Current Liabilities | 4.14M | 3.24M | 2.36M | 1.69M | 3.31M |
| Total Current Liabilities | 78.17M | 50.28M | 41.91M | 37.75M | 51.05M |
|
|
|||||
| Total Current Liabilities | 78.17M | 50.28M | 41.91M | 37.75M | 51.05M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 6.00M | 6.17M | 6.80M | 6.66M | 4.77M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 15.40M | 16.30M | 17.18M | 17.86M | 16.23M |
| Total Liabilities | 99.57M | 72.76M | 65.89M | 62.27M | 72.05M |
|
|
|||||
| Common Stock & APIC | 1.52B | 1.20B | 1.18B | 1.15B | 1.13B |
| Retained Earnings | -895.03M | -800.71M | -721.28M | -643.35M | -569.93M |
| Treasury Stock & Other | -2.95M | -4.20M | -3.98M | -3.43M | -2.11M |
| Total Common Equity | 626.22M | 394.90M | 451.44M | 506.92M | 558.19M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 626.22M | 394.90M | 451.44M | 506.92M | 558.19M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 626.22M | 394.90M | 451.44M | 506.92M | 558.19M |
|
|
|||||